BMS extends its cost-cutting drive by another $2bn RFK Jr odds on for HHS role after Finance Committee vote News First self-amplifying mRNA vaccine reaches Europe Arcturus Therapeutics and CSL's COVID-19 vaccine Kostaive is the first in the new sa-mRNA class to be approved for marke...
In most cases, a central BMS is required, with specialized management software linked to various sensors that monitor conditions in the building. The BMS uses wired or wireless networks to connect a variety of specialized sensors that capture performance data from various building controls. A large ...
This has been due in part to AbbVie’s exceptional performance in the market, rising to become one of the industry’s lead players. AbbVie is also forecast to become the biggest pharma company by 2028. In the company’s latest earnings report, worldwide net revenues decreased 5.4% to $14...
Ian Wyglendowski has experienced the pharma industry with companies of every size. He started his career at a small biotech (35 employees) and then went to work for Genetics Institute/ Wyeth and BMS. Throughout his career, he also worked with numerous CROs and today is the head of strategi...
“Samsung Biologics will complete the construction of its fourth plant in the first half-year and pushes to build four more factories. Celltrion is building its third plant, and Lotte Biologics plan to build three CMO plans with a capacity of 120,000 liters,” the report said. “Given the...
Aaron Mitchell, Principal at ZS Associates also believes that data and analytics are the key to value-based healthcare. “Pharma is facing an evolving evidence landscape requiring new data sources and analytical methods to address new clinical endpoints that demonstrate the value of therapies.” With...
As Big Pharma reduces overheads, reorganises monolithic R&D structures, and suffers loss of market share after blockbuster patent expiry, it is time, perhaps, to take some lessons from mid-tier and specialty pharma. Specialty and mid-tier pharma Specialty and mid-tier pharma have operated ...
HBME1 HBMEC HBMF HBMG HBMGC HBMHS HBMI HBMIB HBMIS HBMK HBML HBMLP HBMN HBMO HBMOS HBMP HBMR HBMS HBMSC HBMSCC hBMSCs HBMV HBMWD HBN HBNA HBNC HBNF HBNI HBNM hBNP HBNQ HBNR HBNRC HBNS HBNSI HBNW HBNWR HBO ▼
R.G.-C. has provided scientific advice and/or received honoraria or funding for continuous medical education from AAA, Advanz Pharma, Amgen, Bayer, BMS, HMP, Ipsen, Merck, Midatech Pharma, MSD, Novartis, PharmaMar, Pfizer, Pierre Fabre, Roche, Servier and Sanofi, and has received research ...
Disclosure of Interests: Laure Gossec Grant/research support from: AbbVie, BMS, Celgene, Janssen, Lilly, MSD, Novartis-Sandoz, Pfizer, Sanofi, and UCB, Consultant for: AbbVie, Biogen, BMS, Celgene, Janssen, Lilly, MSD, Nordic Pharma, Novartis-Sandoz, Pfizer, Roche, Sanofi, and UCB, ...